Why a diabetes drug fell short of anticancer hopes
Ars Technica » Scientific Method 2024-10-12
Summary:
Studies suggested it could treat cancer, but the clinical trials were a bust.
Link:
https://arstechnica.com/health/2024/10/why-a-diabetes-drug-fell-short-of-anticancer-hopes/From feeds:
Cyberlaw » Ars TechnicaMusic and Digital Media » Ars Technica
Berkeley Law Library -- Reference & Research Services » Ars Technica » Scientific Method